Commit To Buy GenMark Diagnostics At $5, Earn 20.1% Annualized Using Options
October 18, 2018 at 11:51 AM EDT
Investors eyeing a purchase of GenMark Diagnostics, Inc. (GNMK) shares, but tentative about paying the going market price of $6.32/share, might benefit from considering selling puts among the alternative strategies at their disposal..